GE HealthCare Technologies Inc. (GEHC)
| Market Cap | 41.74B |
| Revenue (ttm) | 19.67B |
| Net Income (ttm) | 1.99B |
| Shares Out | 457.30M |
| EPS (ttm) | 4.34 |
| PE Ratio | 21.03 |
| Forward PE | 19.45 |
| Dividend | $0.14 (0.15%) |
| Ex-Dividend Date | Jan 14, 2025 |
| Volume | 497,499 |
| Open | 92.33 |
| Previous Close | 92.09 |
| Day's Range | 90.77 - 91.75 |
| 52-Week Range | 74.51 - 94.80 |
| Beta | 1.33 |
| Analysts | Buy |
| Price Target | 97.67 (+7.01%) |
| Earnings Date | Feb 13, 2025 |
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided ther... [Read more]
Financial Performance
In 2024, GEHC's revenue was $19.67 billion, an increase of 0.61% compared to the previous year's $19.55 billion. Earnings were $1.99 billion, an increase of 43.90%.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price forecast is $97.67, which is an increase of 7.01% from the latest price.
News
Enlitic and GE HealthCare to Collaborate to Redefine Imaging Data Migration and Cloud Solutions for Enterprise Imaging
FORT COLLINS, Colo., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Enlitic, Inc., (ASX:ENL) a leader in healthcare imaging data solutions, and its subsidiary Laitek, announces a collaboration with GE HealthCare, ...
Why Is GE HealthCare Stock Trading Soaring On Thursday?
On Thursday, GE HealthCare GEHC reported fourth-quarter adjusted EPS of $1.45, up from $1.18 a year ago, beating the consensus of $1.26.
GE HealthCare Technologies Inc. (GEHC) Q4 2024 Earnings Call Transcript
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief IR Officer Peter Arduini - President and CEO...
GE HealthCare forecasts upbeat 2025 profit on steady medical device demand
GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its medical devices in markets such as the U.S. to offset weakness in China.
GE HealthCare Posts Q4 Profit Above Expectations
GE HealthCare (GEHC) reported better-than-expected fourth-quarter profit on Thursday, while sales were in line with analysts' estimates.
GE Healthcare's business grows with boost from imaging and diagnostic drug units
Medical-technology company's revenue falls slightly short of estimate, but adjusted profit beats target.
GE HealthCare Stock Rises on Strong Earnings and Outlook
The medical imaging company issues solid guidance for 2025.
GE HealthCare reports fourth quarter and full year 2024 financial results
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2024. GE HealthCare President and CEO Peter Arduini said...
GE HealthCare management to present at upcoming investor conference
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at Citi's 2025 Medtech and Life Sciences Access Day on February 27, 2025 at 2:15pm...
GE HealthCare Technologies: Still A Solid Long-Term Play
GE HealthCare Technologies, spun off from General Electric in 2023, has shown significant stock growth, outperforming the S&P 500 by a wide margin. Despite mixed financial performance, the company rem...
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE HealthCare invests $138 million in Cork, Ireland manufacturing facility to address increasing contrast media demand.
GE HealthCare named to 2025 Fortune World's Most Admired Companies™ list
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has been named to 2025 Fortune World's Most Admired Companies™ list. The company has been recognized across several categories including the qual...
GE HealthCare unveils enhanced Voluson Expert Series women's health ultrasound systems with focus on early detection and exam efficiency
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of Voluson™ ...
China External Cardiology Remote Monitors Market Outlook to 2033, with Key Companies Shenzhen Mindray Bio-Medical Electronics Co., Nihon Kohden and GE HealthCare Technologies
Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "China External Cardiology Remote Monitors Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The comprehensive databook ...
University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology
SAN FRANCISCO--(BUSINESS WIRE)--University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE HealthCare today announced the launch of a Care Innovation Hub, a joi...
Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging
SACRAMENTO, Calif.--(BUSINESS WIRE)--Sutter Health and GE HealthCare (Nasdaq: GEHC) today announced a seven-year strategic enterprise partnership, known as a Care Alliance, that aims to increase acces...
GE HealthCare Stock Gains After Jefferies Analysts Name It 'Franchise Pick'
GE HealthCare Technologies (GEHC) shares gained Wednesday after Jefferies analysts called the stock a “franchise pick” and made a bullish case for the company's diagnostic imaging business.
Stock Of The Day: Where Will The GE HealthCare Rally End?
GE HealthCare Technologies Inc. GEHC shares are trading higher Wednesday. The stock was upgraded from Hold to Buy, while the price target was raised from $95 to $103 by Jefferies.
United States External Cardiology Remote Monitors Market Outlook to 2033 Featuring Key Players, GE HealthCare, Shenzhen Mindray Bio-Medical Electronics, and Nihon Kohden
Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "United States External Cardiology Remote Monitors Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The databook report...
2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens
GE HealthCare shares have surged nearly 27% since October 2023, driven by AI-driven strategies and innovation in healthcare diagnostics, despite some volatility in revenue growth. The bullish outlook ...
GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its fourth quarter and full year 2024 financial results before the market opens on Thursday, February 13, 2025. The GE HealthCare m...
GE HealthCare: Growth Acceleration In 2025 Can Drive Stock Higher
GE HealthCare Technologies is rated a buy due to strong growth prospects, a healthy backlog, and favorable valuation compared to peers. The company's revenue growth is supported by new product innovat...
GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) unveiled three new advanced deep learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the Rad...
GE HealthCare showcases commitment to sustainable innovation at RSNA 2024
CHICAGO--(BUSINESS WIRE)--As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (Nasdaq: GEHC) is highlighting several solutions ...